Millions of American smokers suffer from a potentially serious lung disease that's not technically chronic obstructive pulmonary disease (COPD), a new study finds.
Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.
Despite a federal ban that has removed many flavored vapes from the U.S. market, monthly e-cigarette sales jumped 47% in the first two years of the pandemic, a new government study shows.
